PIC Therapeutics
As Head of In Vitro Pharmacology, Dr. Sturla plays an instrumental role in leading the in vitro Pharmacology program.
She has over 15 years of experience as a cellular and molecular biologist in pediatric and adult oncology and has been the principal investigator of studies of brain tumor patients to identify and validate biomarkers and therapeutic targets.
Dr. Sturla received a BSc with honors from University of Bristol (UK) and a Ph.D. from University of Leeds (UK) in Pediatric Oncology.
PIC Therapeutics
1 followers
PIC Therapeutics is a biotechnology company focused on fundamentally changing how cancer is treated by developing a new generation of therapeutics based on the modulation of RNA translation.